News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
686,519 Results
Type
Article (58089)
Company Profile (225)
Press Release (628205)
Section
Business (190201)
Career Advice (2777)
Deals (34690)
Drug Delivery (98)
Drug Development (78866)
Employer Resources (159)
FDA (15946)
Job Trends (14938)
News (328189)
Policy (31206)
Tag
Academia (2764)
Alliances (49151)
Alzheimer's disease (1253)
Approvals (15915)
Artificial intelligence (189)
Bankruptcy (313)
Best Places to Work (11674)
Biotechnology (150)
Breast cancer (203)
Cancer (1535)
Cardiovascular disease (113)
Career advice (2351)
CAR-T (113)
Cell therapy (330)
Clinical research (63041)
Collaboration (588)
Compensation (234)
COVID-19 (2597)
C-suite (146)
Data (1471)
Diabetes (174)
Diagnostics (6436)
Earnings (67267)
Employer resources (139)
Events (104610)
Executive appointments (517)
FDA (16744)
Funding (525)
Gene therapy (215)
GLP-1 (599)
Government (4532)
Healthcare (19108)
Infectious disease (2687)
Inflammatory bowel disease (117)
Interviews (522)
IPO (15738)
Job creations (3697)
Job search strategy (1980)
Layoffs (465)
Legal (7134)
Lung cancer (221)
Manufacturing (209)
Medical device (13879)
Medtech (13884)
Mergers & acquisitions (19245)
Metabolic disorders (464)
Neuroscience (1613)
NextGen: Class of 2025 (6753)
Non-profit (4495)
Northern California (1790)
Obesity (253)
Opinion (228)
Patents (134)
People (59947)
Phase I (19959)
Phase II (27866)
Phase III (20303)
Pipeline (593)
Postmarket research (2443)
Preclinical (8548)
Radiopharmaceuticals (254)
Rare diseases (278)
Real estate (6336)
Regulatory (21110)
Research institute (2518)
Resumes & cover letters (415)
Southern California (1552)
Startups (3665)
United States (16275)
Vaccines (596)
Weight loss (175)
Date
Today (109)
Last 7 days (430)
Last 30 days (1967)
Last 365 days (34033)
2025 (1838)
2024 (34455)
2023 (39008)
2022 (50000)
2021 (54917)
2020 (53805)
2019 (47605)
2018 (36228)
2017 (32878)
2016 (32415)
2015 (38115)
2014 (30964)
2013 (27151)
2012 (28761)
2011 (29036)
2010 (27382)
Location
Africa (907)
Arizona (174)
Asia (40534)
Australia (7258)
California (4041)
Canada (1498)
China (349)
Colorado (194)
Connecticut (209)
Europe (92675)
Florida (589)
Georgia (150)
Illinois (445)
Indiana (231)
Maryland (693)
Massachusetts (3202)
Michigan (199)
Minnesota (324)
New Jersey (1157)
New York (1156)
North Carolina (813)
Northern California (1790)
Ohio (151)
Pennsylvania (936)
South America (1240)
Southern California (1552)
Texas (607)
Utah (119)
Washington State (423)
686,519 Results for "massachusetts institute of technology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Psychedelics
Massachusetts Bid to Legalize Certain Psychedelic Drugs Fails
Massachusetts residents voted Tuesday against the Natural Psychedelic Substances Act, which would have seen some psychedelics, including psilocybin and dimethyltryptamine, legalized in the state.
October 21, 2024
·
7 min read
·
Heather McKenzie
Job Creations
Massachusetts Increases Life Sciences Investment by $500M Over 10 Years
Massachusetts’ increased investment in the life sciences industry includes boosting its life sciences tax incentive program by $10 million annually, aiding job creation in the state.
November 21, 2024
·
2 min read
·
Angela Gabriel
Job Creations
Massachusetts Tax Incentives for Moderna, Vertex and More Creating 1,155 Jobs
Nineteen companies are receiving $21.4 million total in tax incentive awards to create 1,155 new life sciences jobs in Massachusetts. Moderna and Vertex received the largest awards and will add over 600 combined jobs.
October 24, 2024
·
4 min read
·
Angela Gabriel
Press Releases
Baird Medical Showcased Microwave Ablation Technology at Massachusetts Society of Otolaryngology Event
November 11, 2024
·
2 min read
Job Trends
Improving Talent Recruitment, Retainment Key to Massachusetts Life Sciences: Report
Designed to create hundreds of jobs and add up to $1 billion to Massachusetts’ gross domestic product by the start of 2030, MassBio’s five-year strategic plan addresses challenges including skill gaps and talent shortages.
October 2, 2024
·
4 min read
·
Angela Gabriel
Press Releases
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
January 7, 2025
·
4 min read
Job Trends
Massachusetts’ Biopharma Jobs Grew at Slowed Rate in 2023: Report
Massachusetts’ biopharma jobs increased 2.6% in 2023, according to the MassBio Industry Snapshot. Whether the state’s jobs grow in 2024 remains to be seen based on this year’s layoffs and seemingly slowed hiring based on
BioSpace
data.
August 27, 2024
·
5 min read
·
Angela Gabriel
Press Releases
ClearNote Health’s Avantect® Multi-Cancer Detection Test Selected as One of Two Noninvasive Blood-Based Technologies for National Cancer Institute’s Vanguard Study
January 7, 2025
·
3 min read
Compensation
Pay Range Transparency: New Law Could Help Massachusetts Biopharma Industry
Massachusetts’ new salary range transparency law can be a tool for companies looking to attract biopharma professionals while also helping candidates and current employees improve their job searches and salaries, according to two experts.
August 21, 2024
·
5 min read
·
Angela Gabriel
Immutep successfully completes institutional placement and institutional component of entitlement offer
Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.
June 5, 2024
·
7 min read
1 of 68,652
Next
